Boehringer Ingelheim Biopharmaceuticals GmbH (BioXcellence)
Is this your company? Claim this profile
Drug Product
Advanced Modalities
Company Overview
About
Boehringer Ingelheim Biopharmaceuticals GmbH (BioXcellence) is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Quality Control, Stability Testing, Method Development
Therapeutic Areas
Respiratory
Allergy
Quick Facts
HQ:Germany
Founded:2003
Employees:2,402
Capabilities & Services
Core Capabilities
- Biologics Drug Substance
- Biologics Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Sterile Injectable
Containment Capabilities
BSL-2 (Biosafety Level 2)
Production Scales
Phase III Clinical Trials
Commercial Scale
Clinical
Markets Served
Europe
International Regulatory
EU GMP Certificates
1
Regulatory Bodies
EMA/EudraGMDP
Regulatory Approvals
Drug Approval B9LW78
Health Canada · #APR-RS020M66 · 2020-11-01
Drug Approval YIU7WH
Health Canada · #APR-ML8KOHIE · 2019-03-01
Certifications
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-L3CZ2U61
Issued: 2020-11-12
Expires: 2025-09-22
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-1DDRKBMT
Issued: 2020-10-11
Expires: 2025-03-10
Loading CDMO intelligence...
Key facts about Boehringer Ingelheim Biopharmaceuticals GmbH (BioXcellence)
- Boehringer Ingelheim Biopharmaceuticals GmbH (BioXcellence) is headquartered in Germany.
- Boehringer Ingelheim Biopharmaceuticals GmbH (BioXcellence) was founded in 2003.
- Boehringer Ingelheim Biopharmaceuticals GmbH (BioXcellence) has 2,402 employees.
- Boehringer Ingelheim Biopharmaceuticals GmbH (BioXcellence)'s capabilities include Biologics Drug Substance, Biologics Manufacturing and Formulation Development.
Find CDMOs like Boehringer Ingelheim Biopharmaceuticals GmbH (BioXcellence)
Directory pages this company appears in, each with the full list of matching manufacturers.